R. John Fletcher, Director at Vyant Bio, Inc. (VYNT), bought 30,300 shares at $3.39 ($102K) on 2021-05-24, disclosed to the SEC on 2021-05-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.33 | 15,000 | $50K | 49.1% |
| 2 | $3.39 | 15,300 | $52K | 50.9% |
| Total | $3.36 avg | 30,300 | $102K | 100% |
| Filing → |
| KRMD | BUY | 2020-12-01 | $194K | — | Filing → |
| ACLS | SELL | 2020-05-29 | $1.3M | — | Filing → |
| ACLS | SELL | 2019-12-12 | $470K | — | Filing → |